“…Moreover, studies in mice have shown that transplantation of SAT from lean mice into the visceral cavity has beneficial effects on body weight, glucose metabolism and insulin sensitivity in lean (Tran et al, 2008) and obese (Foster et al, 2013;Hocking et al, 2015) mice. However, the transplantation of pgWAT to subcutaneous sites has resulted in either no (Barrera et al, 2012;Tran et al, 2008) or some metabolic advantages (Satoor et al, 2011;Tran and Kahn, 2010). Thus, the accumulation of VAT is more harmful than peripheral, subcutaneous obesity, increasing the risk of the development of non-alcoholic fatty liver disease and type 2 diabetes (Fox et al, 2007).…”